following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..consider making a donation to support the coverage that shapes the face of berkeley..